Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 24510 | 309 | 33.6 | 68% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 429 | 3 | SPHINGOSINE 1 PHOSPHATE//CERAMIDE//SPHINGOLIPIDS | 27734 |
| 2742 | 2 | LYSOPHOSPHATIDIC ACID//AUTOTAXIN//DIADENOSINE POLYPHOSPHATES | 3231 |
| 24510 | 1 | ENPP1//PC 1//PLASMA CELL MEMBRANE GLYCOPROTEIN 1 | 309 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | ENPP1 | authKW | 726296 | 7% | 35% | 21 |
| 2 | PC 1 | authKW | 648642 | 5% | 41% | 16 |
| 3 | PLASMA CELL MEMBRANE GLYCOPROTEIN 1 | authKW | 494097 | 2% | 100% | 5 |
| 4 | K121Q POLYMORPHISM | authKW | 395278 | 1% | 100% | 4 |
| 5 | NUCLEOTIDE PYROPHOSPHATASE | authKW | 333504 | 3% | 38% | 9 |
| 6 | K121Q | authKW | 296458 | 1% | 100% | 3 |
| 7 | ALKALINE PHOSPHODIESTERASE I | authKW | 225870 | 1% | 57% | 4 |
| 8 | PHOSPHODIESTERASE I | authKW | 201746 | 2% | 29% | 7 |
| 9 | DEV GERIATR MED | address | 197639 | 1% | 100% | 2 |
| 10 | ECTOENZYME NUCLEOTIDE PYROPHOSPHATE PHOSPHODIESTERASE 1 | authKW | 197639 | 1% | 100% | 2 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Endocrinology & Metabolism | 1752 | 29% | 0% | 91 |
| 2 | Biochemistry & Molecular Biology | 366 | 31% | 0% | 96 |
| 3 | Medical Laboratory Technology | 101 | 3% | 0% | 10 |
| 4 | Biophysics | 61 | 6% | 0% | 19 |
| 5 | Nutrition & Dietetics | 57 | 4% | 0% | 13 |
| 6 | Cell Biology | 43 | 8% | 0% | 25 |
| 7 | Medicine, Research & Experimental | 25 | 5% | 0% | 14 |
| 8 | Genetics & Heredity | 20 | 5% | 0% | 15 |
| 9 | Biochemical Research Methods | 18 | 4% | 0% | 11 |
| 10 | Oncology | 15 | 6% | 0% | 18 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | DEV GERIATR MED | 197639 | 1% | 100% | 2 |
| 2 | ENDOCRINOL OSPED GARIBALDI | 197639 | 1% | 100% | 2 |
| 3 | UNIT DIABET ENDOCRINE DIS | 196001 | 4% | 18% | 11 |
| 4 | CARDIOVASC RHEUMAT DIS NISKA BANJA | 131758 | 1% | 67% | 2 |
| 5 | UNITA RIC ENDOCRINOL | 121618 | 1% | 31% | 4 |
| 6 | INTERNAL MED ENDOCRINE METAB DIS | 105402 | 1% | 27% | 4 |
| 7 | BIOCHEM INFORMAT | 98819 | 0% | 100% | 1 |
| 8 | BIOMED SCI CELLULAR BIOCHEM | 98819 | 0% | 100% | 1 |
| 9 | BIOMED SCI PROT SCI PROTE EPIGENET SIG | 98819 | 0% | 100% | 1 |
| 10 | CARIBALDI HOSP | 98819 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | METHODS IN CANCER RESEARCH | 5199 | 0% | 5% | 1 |
| 2 | DIABETES | 4731 | 8% | 0% | 24 |
| 3 | METABOLIC SYNDROME AND RELATED DISORDERS | 647 | 1% | 0% | 2 |
| 4 | OBESITY | 605 | 2% | 0% | 5 |
| 5 | DIABETOLOGIA | 573 | 2% | 0% | 7 |
| 6 | CLINICA CHIMICA ACTA | 562 | 3% | 0% | 8 |
| 7 | NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 541 | 0% | 1% | 1 |
| 8 | EUROPEAN JOURNAL OF BIOCHEMISTRY | 486 | 3% | 0% | 10 |
| 9 | JOURNAL OF COMMUNITY HEALTH NURSING | 430 | 0% | 0% | 1 |
| 10 | BIOCHEMICAL AND MOLECULAR MEDICINE | 413 | 0% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | GOLDFINE, ID , MADDUX, BA , YOUNGREN, JF , REAVEN, G , ACCILI, D , TRISCHITTA, V , VIGNERI, R , FRITTITTA, L , (2008) THE ROLE OF MEMBRANE GLYCOPROTEIN PLASMA CELL ANTIGEN 1 ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 IN THE PATHOGENESIS OF INSULIN RESISTANCE AND RELATED ABNORMALITIES.ENDOCRINE REVIEWS. VOL. 29. ISSUE 1. P. 62-75 | 58 | 48% | 53 |
| 2 | HSIAO, TJ , LIN, E , (2016) THE ENPP1 K121Q, POLYMORPHISM IS ASSOCIATED WITH TYPE 2 DIABETES AND RELATED METABOLIC PHENOTYPES IN A TAIWANESE POPULATION.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 433. ISSUE C. P. 20 -25 | 34 | 68% | 0 |
| 3 | ABATE, N , CHANDALIA, M , DI PAOLA, R , FOSTER, DW , GRUNDY, SM , TRISCHITTA, V , (2006) MECHANISMS OF DISEASE: ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 AS A 'GATEKEEPER' OF INSULIN RECEPTORS.NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM. VOL. 2. ISSUE 12. P. 694 -701 | 40 | 68% | 24 |
| 4 | BOLLEN, M , GIJSBERS, R , CEULEMANS, H , STALMANS, W , STEFAN, C , (2000) NUCLEOTIDE PYROPHOSPHATASES/PHOSPHODIESTERASES ON THE MOVE.CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 35. ISSUE 6. P. 393 -432 | 60 | 44% | 184 |
| 5 | SORTICA, DA , CRISPIM, D , ZAFFARI, GP , FRIEDMAN, R , CANANI, LH , (2011) THE ROLE OF ECTO-NUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 IN DIABETIC NEPHROPATHY.ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA. VOL. 55. ISSUE 9. P. 677-685 | 37 | 64% | 5 |
| 6 | DIMATTEO, C , MARUCCI, A , PALAZZO, A , CISTERNINO, C , MARSANO, RM , TRISCHITTA, V , DI PAOLA, R , (2013) ROLE OF SOMATOMEDIN-B-LIKE DOMAINS ON ENPP1 INHIBITION OF INSULIN SIGNALING.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. VOL. 1833. ISSUE 3. P. 552-558 | 24 | 89% | 2 |
| 7 | BACCI, S , DE COSMO, S , PRUDENTE, S , TRISCHITTA, V , (2007) ENPP1 GENE, INSULIN RESISTANCE AND RELATED CLINICAL OUTCOMES.CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE. VOL. 10. ISSUE 4. P. 403-409 | 42 | 58% | 16 |
| 8 | ZHOU, HH , CHIN, CN , WU, M , NI, WH , QUAN, S , LIU, F , DALLAS-YANG, Q , ELLSWORTH, K , HO, T , ZHANG, AW , ET AL (2009) SUPPRESSION OF PC-1/ENPP-1 EXPRESSION IMPROVES INSULIN SENSITIVITY IN VITRO AND IN VIVO.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 616. ISSUE 1-3. P. 346-352 | 26 | 84% | 15 |
| 9 | CHIN, CN , DALLAS-YANG, Q , LIU, F , HO, T , ELLSWORTH, K , FISCHER, P , NATASHA, T , IRELAND, C , LU, P , LI, C , ET AL (2009) EVIDENCE THAT INHIBITION OF INSULIN RECEPTOR SIGNALING ACTIVITY BY PC-1/ENPP1 IS DEPENDENT ON ITS ENZYME ACTIVITY.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 606. ISSUE 1-3. P. 17-24 | 27 | 79% | 17 |
| 10 | TANYOLAC, S , BREMER, AA , HODOGLUGIL, U , MOVSESYAN, I , PULLINGER, CR , HEINER, SW , MALLOY, MJ , KANE, JP , GOLDFINE, ID , (2009) GENETIC VARIANTS OF THE ENPP1/PC-1 GENE ARE ASSOCIATED WITH HYPERTRIGLYCERIDEMIA IN MALE SUBJECTS.METABOLIC SYNDROME AND RELATED DISORDERS. VOL. 7. ISSUE 6. P. 543 -548 | 24 | 89% | 7 |
Classes with closest relation at Level 1 |